Columbia's AI finds needle-in-a-haystack sperm after 18-year struggle

After 18 years of heartbreak, countless IVF cycles, and trips to fertility clinics around the globe, one couple is finally expecting a baby.

The culprit behind their nearly two-decade struggle was azoospermia, a severe form of male infertility where semen contains virtually zero detectable sperm. Under a microscope, lab techs usually just see cell fragments.

Desperate for answers, they turned to the Columbia University Fertility Center, where an AI system managed to spot three viable sperm cells in the husband's sample. That was all it took for a successful IVF cycle. The baby is due in December.

8 million images in an hour

The breakthrough comes courtesy of the STAR method, which stands for Sperm Tracking and Recovery. Developed over five years by Dr. Zev Williams and his team, the system pairs a high-speed camera with advanced computer vision.

A patient drops off a semen sample on a micro-engineered chip under a microscope. STAR scans the fluid at breakneck speed, snapping more than 8 million images in under an hour.

The moment the algorithm identifies the distinctive shape of a sperm cell, it gently isolates it into an ultra-tiny fluid droplet. Because the process avoids harsh chemical stains or lasers, the fragile cells remain completely unharmed and ready for IVF.

In early bench trials, skilled human embryologists spent two grueling days scouring a single patient's sample and found nothing. STAR scanned the exact same sample and flagged 44 viable sperm in 60 minutes.

Sparing men the scalpel

Male factors contribute to nearly 40% of all infertility cases, and azoospermia affects up to 10% of those men. It often blindsides patients because physical health, sexual performance, and the semen itself appear totally normal.

Until now, the standard workaround was invasive surgery. Doctors would slice open testicular tissue and tear it apart under a microscope hoping to unearth a stray cell. It is painful, carries risks of permanent scarring, and can only be performed a few times before causing irreparable tissue damage.

Williams estimates that running STAR to search, isolate, and freeze sperm will cost just under $3,000 per patient, far cheaper and vastly less traumatic than surgical sperm retrieval.

Still, pioneers in reproductive medicine urge caution. Dr. Gianpiero Palermo of Weill Cornell Medicine warned against giving couples false hope, noting that AI cannot conjure sperm out of thin air. If a man's body simply produces zero sperm, no imaging model in the world will change that.

Why it matters

We think STAR is a textbook example of using AI for what humans are terrible at: relentless, pixel-by-pixel screening without eye strain or bias. Sifting through microscopic debris for two days is an impossible task for an embryologist, but light work for a machine vision pipeline.

For hopeful parents, this changes the timeline of despair. It provides a non-invasive, relatively affordable pitstop before couples resort to third-party donor sperm or give up entirely. If Columbia publishes and licenses the hardware widely, it could quickly become a standard pre-screening step in clinics worldwide.

That said, one successful pregnancy is a miraculous proof-of-concept, not an infallible cure. AI solves the search problem, but it cannot fix severe underlying genetic defects in the gametes themselves. The tech gives nature a much better shot, but human biology still has the final word.